Related by context. All words. (Click for frequent words.) 55 MAb therapy 52 MADRID Traffickers 51 Note Movie showtimes 51 specify Alturas 51 Indicate Pet Ohana 50 Type Inbox 49 disclosure requirements acc 49 risks anduncertainties 49 pulls Darvon painkiller 49 Cytokinetics specified 49 promote ceftobiprole 48 specify G4G News 48 KRYSTEXXA TM 48 BiDil XR 48 specify Victory Nickel 48 Submits Response 48 RAPIDGate Program contains 48 markets HP Acthar 48 BRILINTA 48 Please email news@viewsystems.com 47 OMAPRO ™ 47 Nasdaq IMDC 47 specify Nuinsco Resources 47 risksand uncertainties 47 Vertex hepatitis C 47 lender consents 46 Google Permissions 46 Resubmission 46 presidential runningmate 46 specify Kirrin News 46 Triage Stroke Panel 46 verbally OK'd 46 Pre IND 46 Kyowa Kirin 46 Investigational Device Exemption 46 rThrombin 46 Specifications pricing 46 SILENOR 46 BiDil XR drug 45 Approvable letter 45 Phase IIa clinical trials 45 sNDAs 45 Urocidin TM 45 Risperidone Oral Solution 45 word Rosaforte 45 Bioaccelerate compounds under 45 TranSwitch indebtedness 45 IDE Investigational Device Exemption 45 Announces Tentative Approval 45 Such Grouped Lots 45 Submits Biologics License Application 45 Premarket Approval Application 45 Irinotecan Hydrochloride Injection 45 Stedesa 45 specify Athabasca Minerals 45 Methylphenidate Transdermal System 44 Sanctura XR 44 balsalazide tablet 44 Kynapid 44 Submits Investigational 44 Severe hypersensitivity reactions 44 commercialize CorMedix drug 44 hoFH 44 consents authorizations 44 Dynepo TM 44 Stapleton musical revue 44 Asentar TM 44 TriPath Oncology 44 iii GTx 44 -Magbie 44 please email chris@chfir.com 44 successfully commercialize Iluvien 44 risksassociated 44 redeposit fee 44 please email chelsea@chfir.com 44 EGRIFTA 43 Metabasis stockholders 43 pill Galvus 43 regulatory approval 43 concerning Wowjoint 43 sports@bhamnews.com please put 43 cytokine immunomodulator 43 Surfaxin lucinactant 43 SYCREST 43 LEP ETU 43 KRYSTEXXA TM pegloticase 43 Alpine Skiing Riding 43 Contrave NDA 43 Kiacta 43 Kyowa Pharmaceutical Industry 43 tramiprosate ALZHEMED TM 43 Orthopedic Advisory Panel 43 SMNA analyzes 43 Novartis AG Galvus 43 CEFF financings subject 43 REMOXY NDA 43 jsbiz@journalsentinel.com using 43 Febuxostat 43 rasagiline tablets 43 CapGen Offering 43 successfully commercialize Silenor 43 faropenem medoxomil 43 severe hypercholesterolemia 43 e mail labraham@thebeaconjournal.com 43 iii Cubist 43 please email nadine@chfir.com 43 Onalta ™ 43 BioGlue ® 43 Orphan Status 43 AstraZeneca AZN.L 行情 42 Cintredekin besudotox 42 IL# PE#QQR 42 gepirone ER 42 Generx TM 42 MethyPatch 42 specify Trigon 42 Valortim TM 42 FACTIVE R gemifloxacin 42 Kwang Dong 42 Zemiva TM 42 Hematide ™ peginesatide 42 mesylate tablets approved 42 eprodisate KIACTA TM 42 Approvable 42 Ixempra 42 KIACTA TM 42 enoxaparin sodium injection 42 PrevOnco 42 Impax generic 42 please email ir@g4gresources.com 42 Troxatyl TM 42 Entereg alvimopan 42 CAMPATH 42 AERx iDMS 42 Bionutrics 42 treat enlarged prostate 42 indiplon capsules 42 mention Platinex 42 Release Capsules 42 Valtropin 42 DPX Survivac 42 requisite stockholder 42 naronapride 42 BLA filing 42 BioGlue R 42 Shire PLC SHP.LN 42 gave Makena orphan 42 MAXY alpha 42 OTC Zegerid 42 PLAVIX R patent 42 Entocort 42 Rhucin ® recombinant 42 Arzerra ofatumumab 42 mutually acceptable definitive 42 Campto 42 gabapentin enacarbil 42 BEMA Granisetron 42 Biologic License Application 42 Brilique 42 Nabi HB Intravenous 42 Synerx 42 OvaRex R 42 oral methylnaltrexone 42 rolapitant 41 Barr ANDA 41 XL# anticancer compounds 41 Merck Arcoxia 41 Isis Alnylam 41 informal nonpublic 41 please email catarina@chfir.com 41 Approvable Letter 41 ORBIT II 41 nonsampling error 41 should email jlee@bellwetherreport.com 41 uncertaintiesthat 41 MK #B 41 Conditional Approval 41 Schering Plough Kenilworth NJ 41 Ask Eartha 41 PROLACRIA ™ 41 SILENOR ™ 41 Sycrest 41 compound CIP FENOFIBRATE 41 NV Organon 41 anduncertainties 41 NSE SUNPHARMA 41 zileuton IV 41 histamine dihydrochloride 41 OraTest R 41 ATPace TM 41 miconazole MBT 41 Prokhorov Onexim 41 Hotline Inquiry 41 Expedited Review 41 suchforward looking 41 lucinactant 41 Aloxi Injection 41 Amoxicillin PULSYS Phase III 41 Marketing Authorisation Application 41 exclusive sublicense 41 Miscellaneous Fares 41 Alimta pemetrexed 41 Unregistered users Feedback 41 Alvesco R 41 CIP TRAMADOL ER 41 Eloxatin ® 41 Marketing Approval PMA 41 CRHI 41 Entereg TM 41 FDA Approvable Letter 41 statements arebased 41 known teratogen substance 41 generic Copaxone 41 XP# XP# 41 proprietary Capillary Aerosolization Technology 41 Shire BioChem Inc. 41 Milestone Payment From 41 Valera Pharmaceuticals Inc. 41 Loramyc ™ 40 LSE PFZ 40 IND Investigational New 40 Preotact R 40 Baucus Girlfriend 40 RIGScan CR 40 NYSE Amex PTN 40 Cutanea Life Sciences 40 Velcade bortezomib 40 HepeX B 40 HYVISC R 40 Australian Therapeutic Goods 40 Reverse Takeover 40 Frova ® 40 cintredekin besudotox 40 PUBLISHER 'S NOTICE 40 Eligard ® 40 OTC ZEGERID 40 securityholder approval 40 blow downslope 40 uncertainties 40 Thelin TM 40 Zensana 40 Levoleucovorin 40 Gestiva ™ 40 liver resection surgeries 40 ASX PGL 40 affecting Pennichuck Corporation 40 postmarket surveillance 40 Galida 40 DIFICID ™ 40 regulatory authorizations 40 FDA approvable letter 40 Thalomid R 40 TOCOSOL Camptothecin 40 P#X# antagonist 40 Vectibix panitumumab 40 Anturol TM 40 Bioresearch Monitoring 40 Canvaxin 40 Wolf Haldenstein Investigates 40 Cellegesic 40 KIACTA ™ 40 valtorcitabine 40 Modrenal R 40 Ovation Pharmaceuticals Inc. 40 Salmedix 40 Email itp@enn.ie 40 OREXIGEN 40 Announce Shareholder Approval 40 Zenpep 40 phase IIb trial 40 NerPharMa 40 withrespect 40 Surfaxin LS 40 candidate Ramoplanin 40 Aloprim TM allopurinol sodium 40 Somatuline R Depot 40 CDP# 40 Merger Transaction 40 5 lipoxygenase inhibitor 40 Sonus sole discretion 39 STEDESA 39 highly purified pasteurized 39 assigned PDUFA 39 Xifaxan rifaximin 39 HHonors Terms 39 strict conditionality 39 Phase III LibiGel 39 oral hydromorphone 39 limitedto 39 sports@bhamnews.com please 39 thispress release 39 conditional inter alia 39 LibiGel NDA 39 IMPDH inhibitor 39 Biological License Application 39 without notice.Though 39 CryoSeal 39 cadence regulatory approvals 39 Preotact 39 LidoPAIN SP 39 VALSTAR 39 Biogen Idec Tysabri 39 Agreement constitutes discloseable 39 Plenaxis R 39 CytoFab 39 FSI STREAMS 39 mifamurtide 39 CONBRIZA 39 #L Sterilizer 39 including withoutlimitation 39 ejsinrod@duanemorris.com 39 Stimuvax R 39 Eliquis 39 CAUTIONARY STATEMENT Statements 39 Premarket Approval 39 looking statementsare 39 regulatory approvals 39 Sebivo 39 Erbitux ImClone 39 SURFAXIN 39 Rotarix R 39 FOLOTYN ® 39 Whitewash Waiver 39 novel therapeutic modality 39 LOPROX R 39 CureTech 39 Confirmatory tests 39 HEPLISAV ™ 39 Metformin Hydrochloride 39 Nasdaq MYL 39 DepoBupivacaine TM 39 VYVANSE TM lisdexamfetamine 39 thetransaction 39 INTUNIV TM guanfacine extended 39 HuMax TAC 39 GRAS notification 39 Aclasta Reclast 39 Roche Chugai 39 Zeneus 39 mutually satisfactory definitive 39 alvimopan 39 Targretin capsules 39 Progenta TM 39 constitutes discloseable transaction 39 sumatriptan DosePro 39 NitroMed BiDil 39 Marketing Authorisation Application MAA 39 Fast Track Status 39 Omapro 39 Cc fields 39 Fast Track designations 39 blood thinner prasugrel 39 symbol WLL 39 Transkaryotic Therapies TKTX 39 Thalidomide Pharmion 39 Inc. NYSE MYL 39 consummating acquisitions 39 SurModics Pharmaceuticals 39 Collategene 39 R sipuleucel T 39 heterozygous FH 39 Promacta 39 department prohibited SanGar 39 subsidiaries visit http:/www.apricusbio.com 39 granted Ortec 39 Wyeth Torisel 39 Cutanea 39 commercialized DURECT 39 Impax ANDA 39 Kissei Pharmaceutical 39 Fortigel 39 Nonproprietary information 39 sirtuin modulators 39 Somaxon ability 39 Lorqess 39 ComfortScan system 39 GRALISE 39 RAPTIVA R 39 Evoltra TM 39 Certriad 39 Receives Tentative FDA 39 Submits Application 38 aresubject 38 Hexion Proposal 38 regardingthe 38 symbol KMI 38 TRANSDUR Sufentanil 38 e mail features@recordnet.com 38 Osiris retains 38 designated Restanza 38 MZF 38 FavId 38 intravenous AAT 38 Exalgo 38 Flutiform ™ 38 Amlodipine Besylate 38 Synerx Pharma 38 IV acetaminophen 38 IS STREAMS 38 Sular formulation 38 Basilea Toctino R 38 OvaRex ® MAb 38 repopulate CNS 38 Applications ANDA 38 Intermezzo ® NDA 38 orally bioavailable compound 38 premerger notification 38 Immtech clinical trials 38 CG STREAMS 38 Waratah Coal filings 38 OLEPTRO 38 Accelerated Assessment 38 TRISENOX ® 38 Files Investigational 38 Lambert Eaton Myasthenic 38 Gentamicin Surgical Implant 38 e mail lsherwin@thebeaconjournal.com 38 Troxatyl 38 Saforis 38 USFDA approval 38 Heska reliance 38 XIAPEX 38 Symbicort asthma 38 Favrille filings 38 pancreatic enzyme replacement 38 Cintredekin Besudotox 38 large tonnage epithermal 38 SonoPrep device 38 Flutiform TM 38 PharMerica LTC Transaction 38 BugOil R 38 CLIRS trial 38 compliance therewith 38 BioDelivery Sciences Announces 38 paliperidone palmitate 38 Proposed Arrangement 38 Taiho Pharmaceutical 38 Http :/ www.irinnews.org copyright 38 Aegerion 38 Trobalt 38 Rotarix ® 38 Cladribine 38 Biologic License Application BLA 38 write Vox Populi 38 Xenazine ® 38 k Premarket Notification 38 symbol EVR 38 specify Eaglecrest 38 AnorMED expectation 38 CHMP recommendation 38 UCB Cimzia 38 customary regulatory approvals 38 Topiramate Tablets 38 Miochol E 38 Arzerra TM 38 SFDA approval 38 Joulferon 38 initiate Phase IIb 38 Velac 38 Retacrit 38 specify Serica press 38 Exelon Patch 38 Company Skouries Olympias 38 cancellations rescheduling 38 ANDA submission 38 AFSSAPS 38 Memryte 38 cicletanine 38 Fanapt ™ 38 requiring Asthmatx 38 BioSante licensees 38 Pirespa 38 Bonefos 38 NeoLipid drug 38 Proposed Financing 38 zileuton CR 38 carcinogenicity studies 38 securityholder approvals 38 Egrifta 38 GTC recombinant form 38 AcryMed Incorporated 38 authority Gurian Sherman 38 Scrip Dividend Scheme 38 Exalgo TM 38 Cetirizine Hydrochloride Syrup 38 CIMZIA r 38 Sumavel DosePro 38 dimesylate Attention Deficit 38 Lexiscan TM 38 IND submission 38 IV APAP 38 otherfactors 38 ACEON R perindopril erbumine 38 sNDA submission 38 Allovectin 7 r 38 pivotal bioequivalence 37 drug Mylotarg 37 User Fee Act 37 Proposed Disposition 37 EGRIFTA TM 37 donepezil hydrochloride 37 Eligard R 37 Daytrana TM 37 Preos 37 diagnostic radiopharmaceutical 37 Voraxaze 37 MVLWB 37 multiple usernames 37 IoGen 37 AMEX IVX LSE IVX.L 37 Orapred ODT 37 statementsregarding 37 EPIX Pharmaceuticals 37 BEXXAR 37 sumatriptan injection 37 Amitiza ® 37 Kalbitor 37 GLP toxicology studies 37 Evoltra 37 Historian Antonia Fraser 37 HSR clearance 37 CRMD# 37 LE SN# 37 PMA Supplement 37 Soliris TM eculizumab 37 SNY SAN.FR 37 Nabi HB R 37 metal detector scans 37 may contact mchamplin@infocomm.org 37 regarding Heska 37 European Medicines Evaluation 37 NESINA 37 Seikagaku 37 under Investor Relations-Documents/Filings 37 Unmarketable Parcel 37 SUMAVEL 37 GTC recombinant human 37 Shigamabs R 37 Ipsen SA 37 Nycomed GmbH 37 aerosolized AAT 37 Enjuvia 37 Increlex TM 37 spokeswoman Lenore Gelb 37 Prednisporin 37 RIGScan ™ 37 Vanacker described 37 Bellus Health 37 ENGINEERING.com Incorporated Announces 37 Adventrx 37 Accelerated Approval 37 Unifill TM syringe 37 pharmacist Olga Kopetman 37 tolevamer 37 reflect Medicago 37 FDA Psychopharmacologic Drugs 37 Regulatory Approvals 37 Pharmachem Offer 37 AMITIZA lubiprostone 37 disinterested Shareholder approval 37 EHT AGN 37 ANDA abbreviated 37 Combidex 37 APNB 37 PrevOnco ™ 37 exemption IDE 37 Oracea ® 37 Chaim Lebovits President 37 dissector@mediachannel.org 37 party payor reimbursement 37 Tekamlo 37 ZEGERID Capsules 37 Nebido 37 inhaled AAT 37 Queenston QA QC 37 These statementsare 37 Clearford Announces 37 Receives Conditional 37 RAPTIVA r 37 ORTHOVISC mini 37 lorcaserin NDA 37 Sumatriptan Succinate 37 PD2i Analyzer 37 Rozetta Cell 37 candidate AQ4N 37 Daewoong 37 Somatuline Autogel 37 apaziquone 37 ZEGERID Powder 37 Fanapt TM 37 Generx ™ 37 Primera Bioscience 37 Ofirmev 37 drug belatacept 37 Safe Harbors created 37 PentaLyte R 37 Lexiscan R 37 reflect Ronn Motor 37 info@m2.com 37 granted orphan medicinal 37 Urokinase 37 pediatric exclusivity 37 Esbriet ® 37 confirmatory Phase III 37 Dr. Rafel Rieves 37 alogliptin 37 Unica disclaims any 37 developing ostarine selective 37 Lumacan 37 ENRICH trial 37 COPmagazine@aol.com 37 Rhucin R 37 dirucotide 37 ZEFTERA TM Zevtera TM 37 MHLW 37 UCB Keppra 37 Linjeta TM 37 synthetic lipoglycopeptide antibiotic 37 Pfizer maraviroc 37 GLASSIA 37 Stavzor 37 finder fee payable 37 Oglemilast 37 TWYNSTA ® 37 sterile lidocaine patch 37 Sanvar R 37 FSAH 37 Apthera 37 SANCTURA R 37 Iluvien ® 37 Medidur FA 37 Famy Care 37 Rescula 37 currentexpectations 36 non waivable 36 supplemental biologics 36 Neose subsequent 36 Firazyr 36 Sertraline Hydrochloride Tablets 36 fund BioSante LibiGel 36 arising therefrom 36 Shigamabs 36 Sherri Childers Arb 36 Call #-#/# [002] 36 EGRIFTA ™ 36 Zytiga 36 Orphan Designation 36 Megapharm Ltd. 36 SOLODYN R 36 Meloxicam Tablets 36 ZALBIN 36 e mail adeluca@globalcustodian.com 36 Novartis Gilenia 36 website www.nyandcompany.com 36 Genentech Roche 36 molecular imaging radiopharmaceutical 36 commercialize alitretinoin 36 commercialize telaprevir 36 Fairness Opinions 36 #-# vphl Norwegian 36 negatives thereof variations thereon 36 Aphthasol R 36 Viviant 36 DC Bead 36 Medigen 36 pontifical secret 36 Tramadol ER 36 Gord Lacey All 36 GenVec cautions 36 Metformin GR 36 results ofoperations 36 AVINZA ® 36 documentation evidencing 36 Rapinyl 36 Exenatide LAR 36 www.timhortons.com en 36 Securite Sanitaire des Produits 36 Manson deprogramming 36 reflect Ronn Motors 36 arebased 36 FIRAZYR 36 subsidiary Glenmark Generics 36 Efient 36 e# periodic 36 affecting Amarin 36 Market Authorization Application 36 Reclast Aclasta 36 Drug Eluting Stent System 36 CHDI Foundation 36 treat atrial flutter 36 Flutiform 36 Kosan dependence 36 Phase IIb clinical trials 36 Entereg R 36 gastrointestinal disorders ATI 36 Exelixis compounds 36 transgenically produced product 36 Evoltra ® 36 Zalbin 36 Novartis Galvus 36 Cimzia TM 36 FastMarkets Ltd 36 histrelin manufacturing marketing 36 Generex Oral lyn tm 36 sNDA filing 36 Orphan Drug Status 36 XENAZINE 36 arenot limited 36 FDA Antiviral Drugs 36 Televangelists escape penalty 36 collaborations Pharmacopeia 36 Somatuline Depot 36 Marketing Authorization Applications 36 regulatory clearances 36 Exelbine 36 Inhibiton 36 Rocmec Closes 36 Oracea TM 36 ELIQUIS 36 Qinnan PSC 36 Cefprozil 36 involverisks 36 Lamictal ODT 36 CORLUX CORT # 36 brentuximab 36 ViroChem Pharma Inc. 36 symbol ZNR 36 raciest GQ photos 36 Acquisition Transaction 36 Amlodipine Besylate Tablets 36 TSX PLB leading 36 Gattex 36 No Objection Letter 36 Novartis NVS Snapshot Report 36 Petrocelli Fastow 36 2 No Harrassing 36 Oncoscience AG 36 Pinelands Wastewater Company 36 shares issuable pursuant 36 Junovan 36 Adcirca 36 Newsminer.com encourages lively 36 Lovaza TM 36 Firdapse ™ amifampridine phosphate 36 eSVS MESH 36 CUSF application 36 Metricath Gemini 36 notlimited 36 oral taxane 36 Covered Person 36 Onrigin 36 Baotou Aluminium 36 Kojo Annan dealings 36 Centralized Procedure 36 TP# CETi 1 36 Kosan motilin agonist 36 Interpharm 36 intravenous acetaminophen 36 vaginal lidocaine 36 Vantas 36 eWorld patent 36 ADSI reliance 36 Graniz Loan 36 Enhanced CRB 36 Pruvel 36 HepaGam B 36 market PolyHeme commercially 36 Menaflex implant 36 Synvisc ONE 36 anomymity 36 caffeine aggravates 36 Physhield Insurance Exchange 36 IntelliPharmaCeutics Ltd. 36 Votrient 36 approval 36 Premarket Approval PMA 36 NCL PMD 36 Advanced Primary Squamous 36 Dyloject TM 36 Calixa 36 Web www.irinnews.org 36 Ceplene histamine dihydrochloride 36 Recommends Approval 36 miconazole Lauriad R 36 EFAPROXYN 36 Somatuline R Autogel R 36 disinterested shareholder 36 Solasia 36 Brinavess 36 Recapitalization Transaction 36 Prednisporin TM 36 PCA Directive 35 Davanat 35 PMA submission 35 Crisa acquisition 35 editor@ilw.com 35 Vitaros R 35 Vaccinogen 35 requisite regulatory approvals 35 sole discretion deems 35 symbol PEH 35 nephropathic cystinosis 35 outlicensed 35 Syntonix 35 Grants Orphan Drug 35 methylnaltrexone 35 looking statementswithin 35 designated cethromycin 35 warrantholder approval 35 Drug Submission 35 Topiramate tablets 35 R isosorbide dinitrate 35 Forward lookingstatements 35 approvable letters 35 intravenous formulations 35 Junovan TM 35 TheraCIM 35 Xechem Nigeria 35 Bioenvision dependence 35 telavancin NDA 35 SEBIVO 35 Biopartners 35 sumatriptan succinate tablets 35 SkillSoft courseware content 35 relation thereto 35 CholeraGarde R Peru 35 CompAir acquisition 35 OLpur TM H2H 35 NASDAQ PGNX 35 Ronald Harwood Adaptations 35 transfusional iron overload 35 Novavax cautions 35 Prodarsan R 35 Mutual Funds Regulations 35 Paragraph IV certifications 35 Marketing Authorizations 35 BigString Corporation intends 35 SansRosa 35 contingently liable 35 subparagraph b 35 Nasdaq NPSP announced 35 prGCD 35 obtaining regulatory approvals 35 Scivanta 35 candidate Zemiva TM 35 Theseforward looking 35 Regulatory Approval 35 PULSYS 35 Emezine 35 IMPELLA R 35 Thesestatements 35 JOULFERON 35 APF# NDA 35 BLA submission 35 HPV vaccine GlaxoSmithKline Cervarix 35 Combination Transaction 35 Yucheng filings 35 PLIVA dd 35 Finansinspektionen 35 Biologics Licensing 35 Marketing Authorization Application 35 FoxHollow stockholders 35 Kirin Pharma 35 symbol LGO 35 orthopedic amputations 35 symbol FGT 35 salting tales 35 Broaching 35 commercialization 35 Sepracor insomnia 35 Alair System 35 MyVax 35 Acetavance TM 35 incur unanticipated 35 Argatroban 35 Gestiva TM 35 VETO SB 35 Subpart H 35 Arranon 35 tivozanib AV 35 Allovectin 7 35 2 BUYER PREMIUM 35 spokesman Ning Shuyong 35 HSR Antitrust Improvements 35 Orathecin 35 e mail hotline@heraldt.com 35 QAB# indacaterol 35 differ materially 35 Zentaris 35 trading symbol TEZ 35 Neurogen stockholders 35 Chase Kishner 35 #D#C# 35 Firazyr ® 35 MCall.com 35 SEDAR www.SEDAR.com 35 DSL.net s 35 spokeswoman Alison Marquiss 35 orphan designation 35 udenafil 35 AzaSite Plus 35 adversely affect Linktone 35 Orexigen Contrave 35 TRANSDUR Bupivacaine 35 Domestic Spying Inquiry Restarted 35 within themeaning 35 GlaxoSmithKline Tykerb 35 ReAble Therapeutics Inc. 35 Numerex cautions 35 foreclosure recission 35 Praecis 35 Laura Stotler writes 35 resubmission 35 BENLYSTA ® 35 DRAXIS 35 Artist Winslow Homer 35 TNRO 35 DYNACIN R Tablets 35 NanoCrystal technology 35 cMET inhibitor 35 Elonva 35 PREGNANT Study 35 Proposed Acquisition 35 Subpart E 35 Julie Hilden 35 Humanitarian Device Exemption 35 Cobalt Pharmaceuticals 35 BrachySil 35 Edgen Corporation 35 indicting Burress 35 Market Approval PMA 35 changesin 35 bilastine 35 symbol WTM 35 PAIVIS intends 35 Biophan patent 35 Melody Transcatheter Pulmonary Valve 35 Marketing Authorisation 35 market fluctuations investee 35 VANTAS 35 Shareholder Approval 35 NYSE AMEX PLX 35 Solzira 35 Acapodene R 35 NFT Warrants 35 thedate hereof 35 determinations de novo 35 treaded softly 35 steroid analogs 34 Trubion stockholders 34 ESTRASORB R 34 Misprinted information 34 Ruconest 34 Shire Attention Deficit 34 applicable regulatory approvals 34 PIX# trial 34 Ventrus 34 candidate XP# 34 Allovectin 7 ® 34 acquire Paxar 34 Candente relies upon 34 EvaMist NDA submission 34 Non Brokered Offering 34 agricultural immigrations 34 Administration TGA 34 voclosporin 34 Hanlong transaction 34 disapplied 34 Receives Stockholder Approval 34 MONOVISC 34 IND CTA 34 midstage studies 34 ADDERALL XR R 34 MAA submission 34 Amyvid 34 Shonin approval 34 fansfceditor@gmail.com putting Football 34 dalbavancin 34 suspensive conditions 34 Financing Condition 34 Onco TCS 34 SAFE HARBOR Statement 34 Vascular Wrap TM 34 Avoid jalapenos 34 telephone Gareth Vorster 34 affect Petroflow 34 PREOS R 34 JHP Pharmaceuticals LLC 34 Prolacria 34 Orphan Drug designations 34 blood thinner rivaroxaban 34 Marketing Authorization Application MAA 34 Scientific Advice 34 AUX Offer 34 Concurrent Financing 34 to submit 34 TOCOSOL Paclitaxel 34 manufacture PolyHeme 34 Diversified Status